Preliminary study of the effect of tokishakuyakusan on ocular blood flow in the patients with normal tension glaucoma
Not Applicable
Completed
- Conditions
- normal tension glaucoma
- Registration Number
- JPRN-UMIN000016865
- Lead Sponsor
- Tohoku university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1. When there is hypotension, circulatory disease, endocrine disease, a cause including excessive anemia are identified, and the cause is judged if treatment is necessary. 2. pregnant 3. history of allergy to Kampo medicine 4. history of unpleasantness, gastrointestinal disorder by the Kampo medicine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocular blood flow
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie tokishakuyakusan's effects on ocular blood flow in normal tension glaucoma patients?
How does tokishakuyakusan compare to standard-of-care treatments for normal tension glaucoma in improving ocular perfusion?
Are there specific biomarkers that predict response to tokishakuyakusan in patients with normal tension glaucoma?
What are the known or potential adverse events associated with tokishakuyakusan use in glaucoma management?
What related compounds or combination therapies show promise in enhancing ocular blood flow for normal tension glaucoma treatment?